HS-IT101 Injection in the Treatment of Advanced Solid Tumors

NCT06342336 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: HS-IT101 Injection

Sponsor

Qingdao Sino-Cell Biomedicine Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]